Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE) announced that its AmpFâ�"STR® MiniFiler™ PCR Amplification Kit has been approved for inclusion in the National DNA Index System (NDIS), a United States Federal Bureau of Investigation database that facilitates the electronic... (Continue reading)
Too many people are self-diagnosing food allergies and could be restricting their diet unnecessarily, according to a new report by the University of Portsmouth and commissioned by the Flour Advisory Bureau. Research shows that up to 20 per cent... (Continue reading)
"Whilst numbers of infections continue to drop we are now in the traditional flu season and I encourage anyone invited to receive a swine flu jab to take up the offer. "We are now vaccinating children aged from six... (Continue reading)
Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms,... (Continue reading)
Pfizer Inc. (NYSE: PFE) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, biologic for the treatment of Dupuytren's... (Continue reading)
IsoRay, Inc. (AMEX:ISR), announced that on October 10, 2009, Dr. Bhupesh Parashar, Dr. A Gabriella Wernicke and Dr. KS Clifford Chao from the Department of Radiation Oncology, and Dr. Jeffery Milsom from the Department of Gastrointestinal Surgery, at Weill Cornell... (Continue reading)
Hearing professionals working in the NHS have a chance to be recognised as the country's best following the launch of an exciting audiology competition. The 2010 Audiologist of the Year award has been launched to find the year's outstanding... (Continue reading)
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary... (Continue reading)
Family doctors in Northern Ireland unveiled on Wednesday a unique 10-year vision in a major bid to tackle healthcare challenges head on - and provide patients with continued access to the best possible services. The Future of General Practice... (Continue reading)
With the new End of Life Assistance Bill being published in the Scottish Parliament, the Scottish Council on Human Bioethics (SCHB) indicated that it was very concerned about the consequences this Bill may have on vulnerable individuals and society. ... (Continue reading)